Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 25 of 25
Full-Text Articles in History
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
Oncolog, Volume 63. Number 03, March 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Local Consolidative Therapy Plus Immunotherapy or Targeted Agents for NSCLC: Clinical trials explore surgery/radiation plus immune checkpoint or tyrosine kinase inhibitors for metastatic non-small cell lung cancer
- INBRIEF: CAR T Cells Elicit Durable Responses in Large B Cell Lymphoma
- Managing Opioid Use in Cancer Patients: Vigilance and interventions ensure patient safety
- Hepatitis C Virus Linked to Head and Neck Cancers: Association of HCV with extrahepatic cancers has implications for HCV testing, treatment
- HOUSE CALL: Understanding cancer Risk and Risk factors-Your risk factors might affect your need for cancer screening
Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt
Oncolog, Volume 63, Number 01, January 2018, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Genitourinary Cancers: Clinical trials explore immune checkpoint inhibitors for bladder, kidney, prostate cancers
- Active Surveillance for Ductal Carcinoma in Situ: COMET trial compares frequent mammography to standard treatment with surgery
- Radiation Plus Chemotherapy for Nasal NK T Cell Lymphoma: Clinical trial may standardize treatment for rare cancer
- HOUSE CALL: Mammography Is Essential for Breast cancer Screening- FDA warns against clinics that advertise screening without mammography
- USEFULRESOURCES: Videoconferences Allow Collaboration in Cancer Prevention, Treatment, Survivorship
Oncolog, Volume 62, Number 09, September 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 09, September 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Laser Interstitial Thermal Therapy for Spinal Metastases: Laser technique may be alternative to open surgery prior to stereotactic radiation therapy for metastases adjacent to the spinal cord.
- Immunotherapy Plus Targeted Therapy for Anaplastic Thyroid Cancer: Trial combines atezolizumab with targeted or cytotoxic agents for patients with anaplastic or poorly differentiated thyroid cancer.
- A New era in Follicular Lymphoma: Newly approved drugs, clinical trials represent shift from cytotoxic to targeted and immunotherapeutic agents.
- HOUSE CALL: Understanding Clinical Trials- Trials provide access to new cancer treatments
- INBRIEF: Repeat Surgery for Close Margins May Be Unnecessary for DCIS Patients Receiving Radiation Therapy
Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt
Oncolog, Volume 62, Number 07, July 2017, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- RAS Mutations and Colorectal Cancer Liver Metastases: Gene mutations may have implications for local therapy for liver metastases from colorectal cancer.
- Active Surveillance for Prostate Cancer: Clinical trial may clarify which patients with prostate cancer will benefit from active surveillance rather than immediate treatment.
- Gut Microbiome May Affect Immunotherapy Response in Melanoma: Metastatic melanoma patients who experience responses to checkpoint inhibitors have a distinct gut bacterial genetic signature.
- HOUSE CALL: Cancer-Related fatigue-Tips for fighting fatigue
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
Oncolog, Volume 62, Number 05-06, May - June 2017, Joe Munch, Bryan Tutt, Kathryn Hale
OncoLog MD Anderson's Report to Physicians (All issues)
- Chimeric Antigen Receptor-Directed Natural Killer Cells for B Cell Malignancies: New take on an experimental therapy holds promise for patients with acute lymphoblastic leukemia, chronic lymphocytic leukemia, other lymphoid cancers.
- Preoperative Exercise Program for Pancreatic Cancer Patients: Prehabilitation regimen to improve functional status during chemotherapy evaluated in clinical trials.
- Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer: Clinical Trial will evaluate immune checkpoint inhibitors in patients with operable early-stage disease.
- HOUSE CALL: Genetic Screening for Hereditary Cancer Syndromes: Genetic counseling, testing help people assess, manage cancer risk
Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson
Oncolog, Volume 62, Number 04, April 2017, Bryan Tutt, Sarah Bronson
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Surgical Management of Lymphedema: New options reduce edema in limbs, improve quality of life for cancer patients with lymphedema.
- Noncytotoxic First-Line Therapy for Mantle Cell Lymphoma: First-line therapy with targeted and immunotherapy agents produces high response rates in mantle cell lymphoma.
- Reports from the Survivorship Research Symposium: Research on BK virus, heart failure, and aspiration in cancer survivors.
- HOUSE CALL: Types of Immunotherapy for Cancer: Understanding different approaches to immunotherapy
Oncolog, Volume 62, Number 03, March 2017, Bryan Tutt, Joe Munch, Brandon C. Strubberg
Oncolog, Volume 62, Number 03, March 2017, Bryan Tutt, Joe Munch, Brandon C. Strubberg
OncoLog MD Anderson's Report to Physicians (All issues)
- Immunotherapy for Glioblastoma: Clinical trials test innovative immunotherapy approaches against brain tumors.
- Virus-Specific T Cells Treat Posttransplant Infections: Banked T cells offer "off-the-shelf" therapy for patients with BK virus, JC virus, Cytomegalovirus infections after stem cell transplant.
- Intensity-Modulated Proton Therapy for Oropharyngeal Cancer: Clinical trial compares outcomes of intensity-modulated proton therapy, standard radiation therapy.
- HOUSE CALL: Lung Cancer Screening-Low-dose computed tomography can detect lung cancer early
Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed
Oncolog, Volume 62, Number 01, January 2017, Bryan Tutt, Joe Munch, Z Ahmed
OncoLog MD Anderson's Report to Physicians (All issues)
- Neoadjuvant Immunotherapy for Melanoma: Trial investigates immune checkpoint blockade in patients with respectable stage III or oligometastatic stage IV disease.
- Radiation May Enhance Immunotherapy for Solid Tumors: Clinical Trials combine immune checkpoint inhibitors with radiation therapy against lung cancers, other solid tumors.
- INBRIEF: Nivolumab Plus Azacitidine Shows Promise in Relapsed Acute Myelogenous Leukemia/ Acute Myelogenous Leukemia, Myelodysplastic Syndrome Study Questions Standard Exclusion Criteria for Conventional Trials
- HOUSE CALL: Social Media Groups for Cancer Patients-Twitter chats, online groups for patients, caregivers
- USEFUL RESOURCES: Resources to Aid Referring Physicians
Oncolog, Volume 61, Number 10, October 2016, Laura L. Russell, Joe Munch, Bryan Tutt, Z Ahmed
Oncolog, Volume 61, Number 10, October 2016, Laura L. Russell, Joe Munch, Bryan Tutt, Z Ahmed
OncoLog MD Anderson's Report to Physicians (All issues)
- Preventing Postoperative Urinary Tract Infections in Cancer Patients: Urinary tract infections (UTIs) increase morbidity, mortality and health care costs and prolong hospitalizations for patients who require urinary catheters-especially those who undergo long, complex surgeries or procedures to treat urological or gynecological cancers. To reduce the incidence of UTIs, clinicians at The University of Texas MD Anderson Cancer Center developed a quality improvement program for surgical patients at the institution.
- Study Offers a Starting Point for Testing Immunotherapy in Rectal Cancer Patients with Deficient DNA Mismatch Repair: A recent study's findings provide a starting point for assessing the efficacy of immunotherapy …
Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell
Oncolog, Volume 61, Number 07, July 2016, Bryan Tutt, Sarah Bronson, Laura Russell
OncoLog MD Anderson's Report to Physicians (All issues)
- Improving Rates of Vaccination after Hematopoietic Stem Cell Transplant: Patients who have undergone a hematopoietic stem cell transplant (HSCT) for a hematological cancer usually lose the immunity they had acquired through vaccination. Although guidelines exist for vaccinating immunocompromised transplant recipients, many patients go unvaccinated or do not complete the series of vaccinations. An ongoing initiative at The University of Texas MD Anderson Cancer Center is using a multipronged approach to improve rates of vaccination after HSCT.
- Bone Loss Prevention in Patients with Cancer: Patients undergoing cancer treatment are at an increased risk of fractures because many cancer therapies tend to …
Oncolog, Volume 61, Number 05, May 2016, Bryan Tutt, Katelyn Werner
Oncolog, Volume 61, Number 05, May 2016, Bryan Tutt, Katelyn Werner
OncoLog MD Anderson's Report to Physicians (All issues)
- Intratumoral Therapies Offer Novel Cancer Treatment Approach: Injecting cancer treatments such as vaccines and genetically modified bacteria and viruses directly into tumors may shrink or destroy the tumors and stimulate an immune response that attacks tumor cells. These treatments have shown promise in clinical trials, and newer trials are exploring whether such treatments can augment the effectiveness of immunotherapy in patients with metastatic or inoperable disease.
- High-Risk Acute Lymphoblastic Leukemia Subtype Targeted in Upcoming Clinical Trial: Early T cell precursor acute lymphoblastic leukemia (ETP-ALL), an uncommon subtype of T cell acute lymphoblastic leukemia (T-ALL), carries a poor prognosis and low …
Oncolog, Volume 60, Number 09, September 2015, Sarah Bronson, Bryan Tutt, K. Nair
Oncolog, Volume 60, Number 09, September 2015, Sarah Bronson, Bryan Tutt, K. Nair
OncoLog MD Anderson's Report to Physicians (All issues)
- Enhanced Surgical Recovery Programs Improve Perioperative Outcomes for Cancer Patients: For patients undergoing cancer surgery, potential complications and long recovery times can delay the delivery of additional life-saving therapy. To improve patients' perioperative outcomes and clear the way for timely administration of additional therapies, several surgical teams at The University of Texas MD Anderson Cancer Center gave begun using enhanced surgical recovery programs (ESRPs).
- New Treatments for Respiratory Viruses in Immunocompromised Patients: Viral respiratory infections are a major concern for immunocompromised patients, in whom such infections are difficult to treat and can lead to pneumonia and even death. Although few …
Oncolog, Volume 60, Number 07, July 2015, Kathryn L. Hale, Bryan Tutt, K. Stuyck
Oncolog, Volume 60, Number 07, July 2015, Kathryn L. Hale, Bryan Tutt, K. Stuyck
OncoLog MD Anderson's Report to Physicians (All issues)
- Emergency Care for Cancer Patients: Medical problems that may seem routine in patients without cancer often mean something different or have a different cause in cancer patients and may be much more serious, requiring urgent treatment. Managing these problems promptly and effectively is a challenge faced by all cancer centers.
- Immunotherapy Trials Offer Hope to Patients with High-Risk or Metastatic Cancer: Although the cure rate for the breast cancer has risen steadily in recent decades, recurrent or metastatic disease remains difficult to control. To fight metastatic breast cancer and forestall the recurrence of high-risk primary disease, researchers at The University …
Oncolog, Volume 57, Number 05, May 2012, Bryan Tutt, Sunni Hosemann
Oncolog, Volume 57, Number 05, May 2012, Bryan Tutt, Sunni Hosemann
OncoLog MD Anderson's Report to Physicians (All issues)
- Advances in Gene Mapping Technology May Accelerate Cancer Drug Development: As new technology makes DNA sequencing faster and less expensive, researchers aim to exploit these abilities to develop novel targeted cancer therapies
- Compass: Advanced Renal Cell Carcinoma: Surgery and/or systemic therapy can help manage disease
- HOUSE CALL: Do Nutritional Supplements Help Prevent Cancer ?: For many people, the risks may outweigh the benefits
- INBRIEF: Drug Provides Symptom Reduction and Survival Advantages for Myelofibrosis Patients
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
Oncology, Volume 56, Number 09, September 2011, Joe Munch, Bryan Tutt
OncoLog MD Anderson's Report to Physicians (All issues)
- Novel Agents for Castrate-Resistant Prostate Cancer Include Potent Androgen Blockers and Immunotherapies: Despite progress in screening and therapy, prostate cancer continues to be a leading cause of cancer death among men worldwide
- New Targeted Therapy Offers Hope in Relapsed Hodgkin and Anaplastic large-Cell Lymphoma: The U.S. Food and Drug Administration (FDA) has approved the first new drug for Hodgkin Lymphoma since 1977
- HOUSE CALL: Colorectal Cancer Screening: Risk factors determine who should be screened and how often
- IN BRIEF: Everolimus may Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer Patients
Oncolog Volume 55, Number 03, March 2010, Bryan Tutt, Joe Munch
Oncolog Volume 55, Number 03, March 2010, Bryan Tutt, Joe Munch
OncoLog MD Anderson's Report to Physicians (All issues)
- Benign Tumors That Cause Big Problems:Fortunately, parathyroid tumors can be removed with minimally invasive surgery.
- Preventing Bone Loss nad Fractures in Cancer Patients
- INBRIEF: Leukemia Cells Observed Burning Fat to Evade Death/Assesment Tool Takes Aim at Graft-versus-Host Disease
- House call: Immunotherapy:Boosting the Body's Fight Against Cancer
Oncolog Volume 51, Number 02, February 2006, Sunni Hosemann, Ellen Mcdonald Phd
Oncolog Volume 51, Number 02, February 2006, Sunni Hosemann, Ellen Mcdonald Phd
OncoLog MD Anderson's Report to Physicians (All issues)
- Emergency Care for Cancer Patients
- Bringing Clinical Trials to the Community
- House Call: Understanding the Immune System
- DiaLog: Cognitive Dysfunction in Cancer, by Christina Meyers, PhD, Professor and Chief, Section of Neuropsychology
Oncolog, Volume 52, Number 03, March 2007, Sunni Hosemann, Karen Stuyck, Elizabeth L. Travis Phd
Oncolog, Volume 52, Number 03, March 2007, Sunni Hosemann, Karen Stuyck, Elizabeth L. Travis Phd
OncoLog MD Anderson's Report to Physicians (All issues)
- New Approaches for Advanced Melanoma
- Helping Patients Stop Smoking
- House Call: Simple Skin Cancer Prevention
- DiaLog: Toward Gender Equity in Academic Medicine, by Elizabeth Travis, PhD, Associate Vice President, Women Faculty Programs
Oncolog Volume 51, Number 05, May 2006, Sunni Hosemann, Kathryn Carnes, Patrick Hwu Md
Oncolog Volume 51, Number 05, May 2006, Sunni Hosemann, Kathryn Carnes, Patrick Hwu Md
OncoLog MD Anderson's Report to Physicians (All issues)
- A Better Kind of Brain Surgery
- Raloxifene Effective for Breast Cancer Prevention
- House Call: The Many Benefits of Massage
- DiaLog: Cancer Vaccines and Immunotherapy, by Patrick Hwu, MD, Professor and Chair, Melanoma Medical Oncology
Oncolog, Volume 50, Number 04, April 2005, Rachel Williams, Ellen Mcdonald, Michael Fisch Md, Mph
Oncolog, Volume 50, Number 04, April 2005, Rachel Williams, Ellen Mcdonald, Michael Fisch Md, Mph
OncoLog MD Anderson's Report to Physicians (All issues)
- Harnessing the Immune System: The Promise and Potential of Cancer Vaccines
- Considering Prophylactic Surgery
- House Call: Chemotherapy and Hair Loss
- DiaLog: Redefining Success in Cancer Care, by Michael Fisch, MD, MPH, Medical Director, Community Clinical Oncology Program
Oncolog, Volume 48, Number 12, December 2003, Karen Stuyck, Dawn Chalaire, Martha A. Askins Phd, Martha Aschenbrenner
Oncolog, Volume 48, Number 12, December 2003, Karen Stuyck, Dawn Chalaire, Martha A. Askins Phd, Martha Aschenbrenner
OncoLog MD Anderson's Report to Physicians (All issues)
- On the Move: Efforts Under Way to Improve Outcomes for Patients with Renal Cancer
- Protocols: Studies Examine Treatments for Renal Cell Carcinoma
- Art Therapy Helps Children Affected by Cancer Express Their Emotions
- Children's Art Project Has Been Improving the Lives of Children with Cancer for 30 Years
- DiaLog: When a Parent Is Sick: Talking to Children about Cancer, by Martha A. Askins, PhD, Division of Pediatrics, and Martha Aschenbrenner, Director, Child Life Services
Oncolog, Volume 47, Number 04, April 2002, Beth Notzon, Karen Stuyck, Felipe Samaniego Md
Oncolog, Volume 47, Number 04, April 2002, Beth Notzon, Karen Stuyck, Felipe Samaniego Md
OncoLog MD Anderson's Report to Physicians (All issues)
- Researchers Focus on Bioimmunotherap for Treatment of Non-Hodgkin's Lymphomas
- Protocols: Non-Hodgkin's Lymphoma Studies
- House Call: The First Cancer Prevention Vaccine
- DiaLog: The Viral Origins of Lymphomas, by Felipe Samaniego, MD, Assistant Professor, Department of Lymphoma and Myeloma
- Research Consortium Recruiting Volunteers to Study the Role of Genetics in Cancer Development and Patient Care
Oncolog, Volume 45, Number 09, September 2000, Mariann Crapanzano, Kerry L. Wright, David L. Callender Md
Oncolog, Volume 45, Number 09, September 2000, Mariann Crapanzano, Kerry L. Wright, David L. Callender Md
OncoLog MD Anderson's Report to Physicians (All issues)
- Multidisciplinary Care Improves Treatment, Enhances Quality of Life for Patients with Colorectal Cancer
- DiaLog: Treating Cancer with a Team Approach, by David L. Callender, MD, Senior Vice President and Chief Medical Officer
- Cervical Cancer Prevention: Could Spectroscopy Steal the Spot"light"?
- Virtual Colonoscopy a Potential Screening Reality
- Protocols: Clinical Trials for Colorectal Cancer
- Compass: Clinical Practice Guidelines
- House Call: Sharing Personal Stories: Books Written by People with Cancer
Oncolog, Volume 44, Number 03, March 1999, Dawn Chalaire, Beth W. Allen, Alison Rufffin
Oncolog, Volume 44, Number 03, March 1999, Dawn Chalaire, Beth W. Allen, Alison Rufffin
OncoLog MD Anderson's Report to Physicians (All issues)
- Vaccines, Other New Options Expand Renal Cancer Therapy Program
- Thirteen-story Alkek Hospital Makes Debut
- Training Takes Prevention and Early Detection Worldwide
- Nephrectomy Before or After Systemic Therapy--That Is the Question
- House Call: Alcohol and Cancer: Making Sense of a Cocktail of Risks and Benefits
- Protocols: Renal Cell Carcinoma Trials Offer Therapies for Treated and Untreated Patients
- Compass: New Quarterly Supplement Offers Perspectives on Clinical Guidelines
Oncolog, Volume 40, Number 03, July-September 1995, Kathryn L. Hale, Vickie` J. Williams, Sunita Patterson
Oncolog, Volume 40, Number 03, July-September 1995, Kathryn L. Hale, Vickie` J. Williams, Sunita Patterson
OncoLog MD Anderson's Report to Physicians (All issues)
- M. D. Anderson leads the fight against bone pain from metastatic cancer
- New computer program enhances the surgeon-patient consultation
- Bladder cancer: molecular markers may guide treatment